Europe Endoscopic Hemostasis Market
市场规模（十亿美元）
CAGR :
% 
USD
675.69 Million
USD
1,183.22 Million
2025
2033
 Forecast Period |
2026 –2033 |
 Market Size (Base Year) |
USD 675.69 Million |
 Market Size (Forecast Year) |
USD 1,183.22 Million |
 CAGR |
% |
| Major Markets Players |
|
歐洲內視鏡止血市場，依產品類型（機械止血裝置、熱力止血裝置、局部用藥及注射劑及其他）、手術（上消化道內視鏡檢查、下消化道內視鏡檢查、支氣管鏡止血及其他）、應用（胃腸道出血、非胃腸道出血、創傷處理及其他）、最終用戶（醫院、門診手術中心、專科及診所
歐洲內視鏡止血市場規模
- 歐洲內視鏡止血市場預計將從2025年的6.7569億美元成長到2033年的11.8322億美元，在2026年至2033年的預測期內，複合年增長率將達到7.7%。
- 受胃腸道疾病盛行率上升、大腸直腸癌、消化性潰瘍和胃腸道出血發病率增加以及該地區微創內視鏡手術日益普及的推動，歐洲內視鏡止血市場正經歷著穩定而強勁的增長。
- 嚴格的臨床指南、對病人安全和手術療效的高度重視，以及對能夠改善手術效果並降低併發症發生率的先進止血技術日益增長的需求，進一步推動了市場成長。內視鏡器械設計的不斷進步，包括改良的止血夾、凝血系統、噴霧劑和聯合療法，正在提升手術的精準性、易用性和臨床療效。
歐洲內視鏡止血市場分析
- 內視鏡止血產品在歐洲醫療保健體系中正變得日益重要，使臨床醫生能夠在診斷和治療性內視鏡手術過程中有效控制胃腸道出血。這些設備透過確保快速可靠的止血，在提高手術安全性、改善臨床療效和促進患者復原方面發揮著至關重要的作用。內視鏡止血解決方案廣泛應用於包括醫院、專科診所和門診手術中心在內的重要臨床場所，用於治療消化性潰瘍出血、結直腸手術、息肉切除術後出血和腫瘤相關出血等。
- 歐洲醫療基礎設施的不斷改進、內視鏡手術量的持續增長以及微創治療方法的日益普及，推動了對內視鏡止血器械的強勁需求。醫療機構正越來越多地採用先進的止血技術，以提高手術效率、降低併發症發生率、縮短住院時間並改善患者的整體預後，從而促進了市場的持續成長。
- 此外，嚴格的臨床指南、對病人安全的日益重視以及不斷加強的監管審查，正在加速先進且經臨床驗證的內視鏡止血解決方案的普及應用。醫療器材製造商正大力投資研發，以開發出在滿足不斷變化的監管標準和臨床性能要求的同時，提供更高精度、更易用性以及與現代內視鏡平台相容性的創新產品。
- 預計到2026年，德國將引領歐洲內視鏡止血市場，佔15.89%的市場。德國的領先地位得益於其完善的醫療基礎設施、龐大的內視鏡手術量、對先進醫療技術的廣泛應用以及眾多領先醫療器械製造商的存在。此外，優惠的醫保報銷政策、高素質的臨床醫護人員以及對醫療創新持續不斷的投入，進一步鞏固了德國在歐洲市場的主導地位。
- 丹麥是歐洲內視鏡止血市場成長最快的國家，這得益於其早期採用數位醫療和先進內視鏡平台、人工智慧輔助診斷和影像導引內視鏡手術的深度整合，以及胃腸和介入內視鏡領域臨床研究的高參與度。該國完善的轉診流程、對日間和門診內視鏡治療的重視，以及臨床醫師對新一代止血設備的快速商業化應用，進一步推動了手術量的成長。此外，醫院、學術機構和醫療器材製造商之間的合作，以及創新技術監管審批流程的簡化，也使丹麥繼續保持領先的早期採用者市場地位，與其他歐洲國家相比，其成長速度更快。
- 機械止血器械在歐洲內視鏡止血市場佔據主導地位，預計2025年將佔43.86%的市場份額。此主導地位主要得益於內視鏡止血夾和套紮器械的廣泛臨床應用，這些器械療效顯著、操作簡便、經濟高效，且適用於多種胃腸道出血適應症。其良好的安全性以及與標準內視鏡手術的兼容性，也持續支撐著醫療機構對這類器械的旺盛需求。
報告範圍及歐洲內視鏡止血市場細分
|
屬性 |
歐洲內視鏡止血市場洞察 |
|
涵蓋部分 |
|
|
覆蓋國家/地區 |
歐洲
|
|
主要市場參與者 |
|
|
市場機遇 |
|
|
加值資料資訊集 |
除了對市場狀況（如市場價值、成長率、細分、地理覆蓋範圍和主要參與者）的洞察之外，Data Bridge Market Research 精心編制的市場報告還包括供應商選擇標準、技術進步、專利分析、監管框架、創新追蹤器和策略分析關稅及對市場的影響。 |
歐洲內視鏡止血市場趨勢
先進微創內視鏡止血技術的應用日益廣泛
- 內視鏡和微創手術在歐洲的穩定發展是推動內視鏡止血器械應用日益普及的主要因素。隨著胃腸道出血、大腸直腸疾病及相關疾病的發生率持續上升，醫療機構越來越依賴先進的止血解決方案，以確保在繁忙的臨床環境中有效控制出血、保障手術安全並改善患者預後。
- 內視鏡止血裝置在診斷和治療性內視鏡手術中發揮著至關重要的作用，確保臨床療效、病人安全和手術可靠性。這些裝置能夠快速控制出血、降低併發症風險並支持微創治療方法，從而優化手術流程，縮短患者恢復時間，並提升醫療機構的整體醫療品質。
- 隨著高清影像、治療性內視鏡和聯合止血技術等先進內視鏡技術的日益普及，對高性能止血解決方案的需求也隨之增長。機械夾、熱凝固系統、注射療法和局部止血劑等方面的創新，在提升手術精準度、治療成功率和臨床醫生信心的同時，也為不斷發展的臨床實踐提供了支持。
- 為了滿足日益嚴格的監管、安全和臨床績效標準，醫療服務提供者在整個醫療服務鏈中越來越多地採用內視鏡止血設備。嚴格的臨床指南、對病人安全和以結果為導向的醫療服務日益重視，以及對微創介入治療需求的不斷增長，都促使醫院和診所整合先進的止血技術，以確保醫療服務的一致性、合規性和高品質。
- 總體而言，內視鏡手術規模的擴大、臨床創新以及醫療基礎設施的完善，使得內視鏡止血裝置成為現代胃腸道護理的重要組成部分。這些解決方案有助於提高手術效率、保障病人安全、符合監管要求，並在歐洲不斷發展的內視鏡領域實現永續發展。透過調整醫療系統動態和應用模式，此經驗可輕鬆應用於其他地區。
歐洲內視鏡止血市場動態
司機
胃腸道出血病例增加
- 胃腸道出血發生率的上升已成為推動全球內視鏡止血市場成長的根本動力。隨著全球上消化道和下消化道出血疾病盛行率的增加，對微創、內視鏡治療的需求也日益增長。內視鏡止血具有許多關鍵的臨床優勢，包括快速止血、減少手術需求、降低輸血需求和縮短住院時間，因此已成為急慢性胃腸道出血治療的第一線治療手段。因此，人口老化、肝病盛行率上升、抗凝血藥物使用以及系統性醫療服務中斷導致的就醫延誤等因素，導致胃腸道出血病例激增，進而促使全球各醫院和內視鏡中心開展更多手術，並更廣泛地採用先進的內視鏡止血設備。
- 例如，
- 2021 年 9 月，Medscape 報告稱，上消化道出血的年發病率約為每 10 萬人口 100 例，並且仍然是急診入院的最常見原因之一，凸顯了需要內視鏡幹預的持續高疾病負擔。
- 2023 年 6 月，《胃腸病學研究》雜誌報道，2012 年至 2021 年間，美國上消化道出血相關死亡率有所上升，且在後期年份上升幅度更大，這表明臨床結果惡化，治療需求加強。
- 2023 年 6 月，StatPearls Publishing 指出，胃腸道出血仍然是全球常見的醫療緊急情況，緊急內視鏡診斷和止血治療對於降低死亡率和發病率仍然至關重要。
- 2025 年 1 月，《臨床醫學雜誌》報告，晚期肝病患者發生大量胃腸道出血的機率明顯更高，這進一步證實了慢性病盛行率與內視鏡止血需求增加之間的關聯。
- 2025 年 9 月，PubMed Central 強調，上消化道出血仍然是慢性肝病患者中危及生命的併發症，因此對內視鏡治療程序的需求持續高漲。
- 全球胃腸道出血發生率的持續上升正逐漸成為內視鏡止血市場長期結構性成長的驅動力。急性出血事件的不斷增加，加上慢性肝病、抗血栓藥物使用以及與年齡相關的胃腸道疾病患者群體不斷擴大，使得內視鏡止血的需求持續且非週期性增長。隨著臨床指引日益重視內視鏡治療作為第一線治療方案，人們對止血技術在緊急介入、預防復發和併發症管理方面的依賴性也日益增強。此外，存活率的提高延長了患者的監測和重複幹預週期，從而成倍增加了終生手術需求。這種動態變化使得內視鏡止血技術的應用與全球流行病學趨勢緊密相關，並使其成為已開發和新興醫療體系中市場擴張的長期基石。
克制/挑戰
內視鏡止血裝置的高成本和技術複雜性
- 儘管內視鏡止血技術在臨床上的應用日益廣泛，但由於先進內視鏡止血設備成本高且技術複雜，歐洲內視鏡止血市場仍面臨結構性限制。這些技術通常需要大量的初始設備購置資金、持續的耗材支出以及專業的維護保養。此外，有效使用止血內視鏡設備需要醫生接受高級培訓、配備熟練的輔助人員以及完善的醫院基礎設施，這限制了成本敏感型醫療系統的應用。中低收入國家的公立醫院，甚至已開發地區預算緊張的醫療機構，也經常面臨與費用、報銷缺口和醫護人員準備不足相關的障礙。因此，先進內視鏡止血技術的普及程度不均，滲透速度緩慢，限制了市場的整體擴張。
- 例如，
- 截至2022年11月，胃腸內視鏡檢查及其設備的高昂費用是限制其發展的主要因素。例如，經口內視鏡檢查（TNE）每次費用為125.90歐元，口腔內視鏡檢查每次費用為184.10歐元，而MACE檢查每次費用為407.10歐元。此外，設備的維護和再處理也增加了成本，僅軟式內視鏡的成本就約為79,330歐元，使得整個檢查過程費用高昂。
- 2024年6月，Science Direct指出，由於缺乏本地維護和維修設施，低收入和中等收入國家（LICs和LMICs）的胃腸內視鏡檢查費用高昂的問題更加突出。需要維修的內視鏡必須運往國外，這會產生高昂的費用和延誤。此外，價格較低的二手內視鏡和中國製造的內視鏡往往缺乏足夠的售後服務和維護支援。
- 2025 年 10 月，《BMJ Open Gastroenterology》發表了一項微觀成本研究，顯示在英國國家醫療服務體系醫院中，可重複使用胃腸內視鏡的每次手術總成本估計為 107.34 英鎊，其中資本成本和維護成本是主要成本驅動因素，這凸顯了公共衛生機構廣泛採用內視鏡設備的經濟障礙。
- 2024 年 8 月，ScienceDirect 的一篇敘述性評論指出，由於設備成本高且缺乏基礎設施，內視鏡設備的購買、維護和相關物流成本仍然是中低收入國家發展和維持內視鏡服務的主要障礙。
- 根據ScienceDirect在2025年2月發布的報告，多項研究表明，胃腸內視鏡檢查成本高昂，尤其是在篩檢和監測方面。例如，雖然在西方地區，對普通人群進行篩檢可能不具成本效益，但針對高風險人群（例如患有胃腸化生的患者）的定向監測仍然具有成本效益，其增量成本效益比（ICER）為每質量調整生命年（QALY）20,739.1美元至98,402.2美元。
- 現有證據清楚地表明，胃腸內視鏡檢查和內視鏡止血器械的高昂成本和技術複雜性持續限制市場成長。設備購置所需的大量資本投入、較高的單次手術成本以及持續的維護、再處理和維修費用，都顯著增加了醫療保健系統的整體成本負擔。在技術基礎設施有限且缺乏本地服務能力的低收入和中等收入地區，這些挑戰更為嚴峻，導致技術推廣應用延遲，手術能力受限。即使在發達的醫療保健系統中，成本效益考量也會影響篩檢策略，限制技術的廣泛應用。總而言之，這些經濟和營運方面的限制減緩了先進內視鏡止血技術的普及，進一步凸顯了價格承受能力和技術複雜性作為市場擴張結構性障礙的重要性。
歐洲內視鏡止血市場範圍
歐洲內視鏡止血市場分為五個主要部分：產品類型、手術、應用、最終用戶和分銷管道。
- 依產品類型
根據產品類型，歐洲內視鏡止血市場可分為機械止血裝置、熱療裝置、局部用藥和注射劑以及其他產品。預計到2026年，機械止血裝置將佔據歐洲內視鏡止血市場的主導地位，市場份額高達43.89%，這主要歸功於其在內視鏡手術中能夠實現即刻、可控且持久的止血效果，因此在臨床上被廣泛採用。諸如止血夾和套紮裝置等機械止血方案因其能夠精準閉合血管且不會造成組織熱損傷而備受青睞，從而降低了再出血率和術後併發症的發生率。這些裝置適用於多種出血情況，包括消化性潰瘍、食道靜脈曲張出血和息肉切除術後出血，因此在急診和擇期內視鏡手術中均廣泛應用。機械止血作為一線治療方法的強大依賴性凸顯了其對整體市場收入的巨大貢獻，並鞏固了其在預測期內該產品類型領域的主導地位。
在歐洲內視鏡止血市場中，局部用藥和注射劑領域是成長最快的領域，複合年增長率達 8.1%。這一增長主要受胃腸道出血性疾病發病率上升、微創內視鏡手術普及以及臨床醫生在急診和擇期手術中對快速起效、易於使用的止血方案的偏好所驅動。
- 按程式
根據操作方式，市場可細分為上消化道內視鏡、下消化道內視鏡、支氣管鏡止血和其他。預計到2026年，上消化道內視鏡將以43.62%的市場份額主導歐洲內視鏡止血市場，這主要歸功於其作為治療急性及復發性消化道出血的一線操作方法的廣泛臨床應用。上消化道內視鏡廣泛應用於出血性潰瘍、食道靜脈曲張出血和迪厄拉福氏病變的診斷和即時治療，在這些情況下，快速止血幹預至關重要。急診和三級醫院的高操作頻率，以及指南對早期內視鏡介入的大力支持，預計將使其市場領先地位得以維持。其持續的主導地位體現在其龐大的市場份額和到 2033 年的穩定成長軌跡上，這表明在已開發和新興醫療保健系統中都存在持續的需求。
在歐洲內視鏡止血市場中，下消化道內視鏡領域是成長最快的細分市場，複合年增長率達 8.1%。這一增長主要受下消化道出血疾病（包括結直腸癌、發炎性腸道疾病、憩室病和痔瘡出血）患病率上升以及歐洲各地篩檢和診斷性大腸鏡檢查程序日益普及的推動。
- 透過申請
根據應用領域，內視鏡止血市場可細分為胃腸道出血、非胃腸道出血、創傷處理和其他領域。預計到2026年，胃腸道出血領域將以71.57%的市場份額主導歐洲內視鏡止血市場，主要歸因於全球消化性潰瘍、食道靜脈曲張和結直腸惡性腫瘤的高發生率，這些疾病均需要內視鏡止血治療。胃腸道出血仍然是內視鏡止血手術最常見的適應症，推動了機械止血、熱力止血和局部止血解決方案在醫院和門診醫療機構的持續應用。快速止血對於降低發病率、縮短住院時間和降低死亡率至關重要，預計這將進一步鞏固該應用領域的需求。其在總市場價值中的高份額凸顯了胃腸道適應症在預測期內塑造整體市場動態的核心作用。
創傷管理領域是歐洲內視鏡止血市場中成長最快的領域，年複合成長率達 8.3%。這一增長主要受創傷性損傷發生率增加的推動，包括腹部創傷、意外傷害和緊急胃腸道出血病例，以及人們越來越傾向於採用微創內視鏡介入治療以快速控制出血。
- 最終用戶
根據最終用戶，內視鏡止血市場可細分為醫院、門診手術中心、專科診所和其他機構。預計到2026年，醫院將以52.69%的市場份額主導歐洲內視鏡止血市場，這主要得益於醫院集中了先進的內視鏡基礎設施、經驗豐富的胃腸病學家以及完善的急診護理能力。包括嚴重的上消化道和下消化道出血在內的複雜出血病例主要在擁有全面診斷和介入治療資源的公立和私立醫院進行治療。病人就診量增加、手術量擴大以及完善的採購系統進一步強化了醫院對內視鏡止血設備和耗材的需求。儘管門診業務逐步成長，但這種對醫院護理的結構性依賴預計將使醫院在2033年之前保持領先地位。
在歐洲內視鏡止血市場中，門診手術中心是成長最快的細分市場，複合年增長率達 8.1%。這一增長主要得益於內視鏡手術從醫院向門診的轉移、對經濟高效且微創的介入治療需求的增加，以及歐洲各地對當日診斷和治療性內視鏡檢查的日益普及。
- 透過分銷管道
根據分銷管道，市場可分為直接銷售和間接銷售，其中間接銷售又可細分為線上和線下通路。預計到2026年，間接銷售將主導歐洲內視鏡止血市場，佔58.48%的最大市場份額，因為採購主要透過經銷商、集團採購組織和區域醫療用品網路進行。間接通路因其能夠提供捆綁產品、庫存管理支援以及更廣泛的地域覆蓋而備受青睞，尤其是在新興市場和分散式醫療體系中。醫院和門診中心通常依賴經銷商主導的採購方式，以確保關鍵止血器械的穩定供應，同時優化採購成本。預計這種分銷結構將在整個預測期內持續推動間接銷售管道的普及。
在歐洲內視鏡止血市場中，間接銷售通路是成長最快的通路，複合年增長率達 7.9%。這一增長主要得益於第三方分銷商、集團採購組織 (GPO) 和區域醫療器材供應商在改善歐洲不同醫療保健系統市場准入方面發揮的日益重要的作用。
歐洲內視鏡止血市場區域分析
- 德國是內視鏡止血器材最重要的市場之一，這得益於其先進的醫療基礎設施、強大的醫療器材製造基地以及微創內視鏡手術的高普及率。胃腸病學領域的持續臨床創新、大量的診斷和治療性內視鏡檢查以及嚴格的臨床和監管標準，正推動先進的機械止血、熱力學止血和局部止血解決方案在醫院和專科護理中心得到穩步應用。
- 隨著胃腸道疾病發病率的上升、人口老化以及對微創治療方法的日益重視，英國對內視鏡止血技術的需求不斷增長，這些因素正在重塑臨床實踐。醫療機構越來越注重提高病人安全、減少手術相關併發症並提升臨床效率，加速了可靠且經濟有效的止血設備在公立和私立醫療機構的應用。
- 法國憑藉其在胃腸病學領域強大的臨床實力、不斷擴大的先進內視鏡服務覆蓋範圍以及日益重視以患者為中心、以療效為導向的醫療服務，正持續崛起為內鏡止血市場的重要增長中心。法國對臨床品質、安全性和技術創新的重視，正促使醫療機構採用先進的止血解決方案，以改善手術效果、支持微創介入治療，並符合不斷發展的監管和醫療標準。
德國內視鏡止血市場洞察
德國內視鏡止血市場正蓬勃發展，這得益於該國龐大的胃腸內視鏡手術量以及對先進治療性內視鏡技術的早期應用。德國的醫院和專科診所高度重視臨床精準性、手術可靠性和循證器械選擇，從而持續推動高性能機械和能量型止血解決方案的需求。此外，領先的醫療器材製造商、完善的臨床培訓體係以及嚴格的監管和品質標準也促進了技術先進的止血器材的快速普及。德國對手術標準化、病人安全和療效優化的重視，鞏固了其作為歐洲技術領先、創新驅動型市場的地位。
英國內視鏡止血市場洞察
隨著醫療機構優先考慮微創治療方案、提高內視鏡中心效率並減少手術相關併發症，英國內視鏡止血市場持續擴張。胃腸道出血疾病發生率的上升，以及英國國家醫療服務體系（NHS）內視鏡服務需求的不斷增長，正在加速經濟高效、易於使用且能支持高手術量的止血設備的普及。對臨床指引、價值導向醫療和標準化治療方案的高度重視正在影響採購決策，而門診和日間內視鏡檢查的日益普及也進一步推動了市場需求。這些因素共同決定了英國內視鏡止血市場的發展方向，即以可近性、效率和可擴展的臨床應用為驅動力，而非設備生產集中度。
歐洲內視鏡止血市場份額
特種食品配料產業主要由一些成熟企業主導，其中包括：
- 微科內視鏡（中）
- 泰雄醫療有限公司（韓國）
- Ovesco Endoscopy AG（德國）
- 阿波羅內視鏡外科公司（美國）
- Argon Medical Devices, Inc.（美國）
- 奧林巴斯株式會社（日本）
- 波士頓科學公司（美國）
- 康美公司（美國）
- 美敦力（愛爾蘭）
- 庫克（美國）
- ERBE Elektromedizin 有限公司（德國）
- Karl Storz SE & Co. KG（德國）
- 賓得醫療（日本）
- Endoskopie Technik Gerhard（德國）
- Merit Medical Systems, Inc.（美國）
- Diversatek公司（美國）
- STERIS plc（英國）
- B. Braun SE（德國）
- Duomed集團（比利時）
歐洲內視鏡止血市場最新進展
- 2025 年 12 月，奧林巴斯透過推出奧林巴斯創新創投基金 II，追加 1.5 億美元，將其企業創投基金承諾增加兩倍，用於投資專注於內視鏡、診斷、數位健康及相關創新領域的醫療技術新創公司，以加強長期成長和技術領先地位。
- 2025年10月，波士頓科學公司宣布達成協議，收購Nalu Medical, Inc.，這是一家專注於植入式神經刺激技術治療慢性疼痛的私人醫療器材公司。此次收購旨在增強波士頓科學公司的神經調控產品組合，加速疼痛管理領域的創新，並擴大慢性疼痛患者的治療選擇。
- 2025年10月，康美公司宣布策略性退出其胃腸病業務，剝離其胃腸產品線及相關資產，以此作為業務組合調整的一部分，專注於核心外科和骨科解決方案。此舉旨在精簡公司的產品重點，加大對高成長手術領域的投資，並透過將資源重新分配至康美公司的旗艦器械平台和新興技術，改善長期收入和利潤率。
- 2025年8月，美國食品藥物管理局（FDA）批准了庫克醫療公司（Cook Medical）的ADVANCE EVERO 18依維莫司塗層PTA球囊導管的首個IDE臨床研究，以便能夠評估其在治療症狀性週邊動脈疾病方面的安全性和有效性。這項決定標誌著藥物塗層球囊技術發展的一個里程碑，支持庫克醫療公司推進下一代血管內治療，旨在降低下肢動脈疾病患者的再狹窄率並改善其長期血管通暢性。
- 7 月，ESGE 發布的局部止血劑指南報告稱，Ankaferd 止血劑在內鏡下用於治療消化性潰瘍和惡性腫瘤等胃腸道出血時，止血率達到 73%-100%。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END-USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTERS FIVE FORCES ANALYSIS
4.2 BRAND OUTLOOK
4.2.1 BRAND COMPARATIVE ANALYSIS OF KEY EUROPE PLAYERS
4.2.1.1 BRAND COMPARATIVE NARRATIVE (ANALYTICAL OVERVIEW)
4.2.2 PRODUCT VS BRAND OVERVIEW — EUROPE ENDOSCOPIC HEMOSTASIS MARKET
4.2.2.1 PRODUCT OVERVIEW — ENDOSCOPIC HEMOSTASIS DEVICES
4.2.2.2 BRAND OVERVIEW — INFLUENCE ON EUROPE CLINICAL ADOPTION
4.3 CONSUMER BUYING BEHAVIOUR
4.3.1 CLINICAL EFFECTIVENESS AND PATIENT OUTCOMES
4.3.2 COST AND VALUE CONSIDERATIONS
4.3.3 COMPATIBILITY AND INTEGRATION
4.3.4 TRAINING REQUIREMENTS AND EASE OF USE
4.3.5 REIMBURSEMENT AND HEALTHCARE POLICY ALIGNMENT
4.3.6 PROCUREMENT PROCESSES AND BULK AGREEMENTS
4.3.7 INFLUENCE OF CLINICAL STAKEHOLDERS
4.3.8 TRENDS IN BUYER BEHAVIOUR
4.3.9 CONCLUSION
4.4 PATENT ANALYSIS
4.4.1 PATENT QUALITY AND STRENGTH – EUROPE ENDOSCOPIC HEMOSTASIS MARKET
4.4.2 COUNTRY PATENT LANDSCAPE
4.4.3 IP STRATEGY AND MANAGEMENT
4.4.4 LICENSING AND COLLABORATION
4.5 RAW MATERIAL COVERAGE
4.5.1 METALLIC COMPONENTS AND ALLOY SYSTEMS
4.5.2 POLYMERIC AND SYNTHETIC MATERIALS
4.5.3 NATURAL AND BIOCOMPATIBLE MATERIALS
4.5.4 ELECTRICAL AND THERMAL MATERIAL SYSTEMS
4.5.5 EXPENDABLE ACCESSORIES AND SINGLE-USE MATERIALS
4.6 TECHNOLOGICAL ADVANCEMENTS IN EUROPE ENDOSCOPIC HEMOSTASIS MARKET
4.6.1 ENHANCED MECHANICAL HEMOSTASIS TOOLS
4.6.2 ADVANCED THERMAL COAGULATION AND ENERGY-BASED SYSTEMS
4.6.3 NOVEL TOPICAL HEMOSTATIC AGENTS
4.6.4 INTEGRATION WITH ADJUNCTIVE DIAGNOSTIC TECHNOLOGIES
4.6.5 DEVELOPMENT OF MULTIFUNCTIONAL AND COMBINATION DEVICES
4.6.6 IMPROVED USER ERGONOMICS AND DEVICE DEPLOYMENT SYSTEMS
4.6.7 CONCLUSION
4.7 VALUE CHAIN ANALYSIS
4.7.1 OVERVIEW
4.7.2 RAW MATERIALS & COMPONENTS
4.7.3 DEVICE DESIGN, R&D & MANUFACTURING
4.7.4 PROCESSING, FINISHING & STERILIZATION
4.7.5 PACKAGING & LABELING
4.7.6 LOGISTICS, DISTRIBUTION & COMMERCIALIZATION
4.7.7 CONCLUSION
4.8 VENDOR SELECTION CRITERIA
4.8.1 CLINICAL PERFORMANCE
4.8.2 REGULATORY COMPLIANCE AND APPROVALS
4.8.3 COST AND TOTAL VALUE PROPOSITION
4.8.4 SUPPLY CHAIN ROBUSTNESS AND LOGISTICS
4.8.5 SUPPORT, TRAINING AND CLINICAL EDUCATION
4.8.6 QUALITY SYSTEMS AND REPROCESSING GUIDANCE
4.8.7 REPUTATION, PEER ACCEPTANCE AND POST-MARKET PERFORMANCE
4.8.8 INNOVATION AND FUTURE-READINESS
4.9 COMPANY EVALUATION QUADRANT
4.1 PROFIT MARGIN SCENARIO
4.10.1 MARGIN IMPROVEMENT DRIVERS
4.10.2 COST PRESSURE
4.10.3 REGIONAL VARIATIONS
4.10.4 FUTURE SCENARIOS
4.11 CLIMATE CHANGE SCENARIO
4.11.1 ENVIRONMENTAL CONCERNS
4.11.2 INDUSTRY RESPONSE
4.11.3 GOVERNMENT’S ROLE
4.11.4 ANALYST RECOMMENDATIONS
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.12.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
4.12.1.1 JOINT VENTURES
4.12.1.2 MERGERS AND ACQUISITIONS
4.12.1.3 LICENSING AND PARTNERSHIP
4.12.1.4 TECHNOLOGY COLLABORATIONS
4.12.2 STRATEGIC DIVESTMENTS
4.12.3 STAGE OF DEVELOPMENT
4.12.4 TIMELINES AND MILESTONES
4.12.5 INNOVATION STRATEGIES AND METHODOLOGIES
4.12.6 RISK ASSESSMENT AND MITIGATION
4.12.7 FUTURE OUTLOOK
4.13 PRICING ANALYSIS
4.13.1 HEMOSTATIC CLIPS AND FORCEPS PRICING
4.13.2 BANDING AND COAGULATION DEVICES
4.13.3 REGULATORY AND REIMBURSEMENT IMPACT
4.14 SUPPLY CHAIN ANALYSIS
4.14.1 OVERVIEW
4.14.2 LOGISTIC COST SCENARIO
4.14.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.14.4 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 OVERVIEW
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS
5.3 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE
5.4 VENDOR SELECTION CRITERIA
5.5 IMPACT ON SUPPLY CHAIN
5.5.1 RAW MATERIAL PROCUREMENT
5.5.2 MANUFACTURING AND PRODUCTION
5.5.3 LOGISTICS AND DISTRIBUTION
5.5.4 PRICE PITCHING AND POSITION OF MARKET
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.6.1 SUPPLY CHAIN OPTIMIZATION
5.6.2 JOINT VENTURE ESTABLISHMENTS
5.7 IMPACT ON PRICES
5.8 REGULATORY INCLINATION
5.8.1 GEOPOLITICAL SITUATION
5.8.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES
5.8.2.1 FREE TRADE AGREEMENTS
5.8.2.2 ALLIANCES ESTABLISHMENTS
5.8.3 STATUS ACCREDITATION (INCLUDING MFTN)
5.8.4 DOMESTIC COURSE OF CORRECTION
5.8.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS
5.8.4.2 ESTABLISHMENT OF SEZS/INDUSTRIAL PARKS
6 REGULATION COVERAGE
6.1 PRODUCT CODES
6.2 CERTIFIED STANDARDS
6.3 SAFETY STANDARDS
6.3.1 MATERIAL HANDLING & STORAGE
6.3.2 TRANSPORT & PRECAUTIONS
6.3.3 HAZARD IDENTIFICATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN GASTROINTESTINAL BLEEDING CASES
7.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI DISORDERS
7.1.3 ADOPTION OF MINIMALLY INVASIVE ENDOSCOPIC PROCEDURES
7.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY
7.2 RESTRAINTS
7.2.1 HIGH COST AND TECHNICAL COMPLEXITY OF ENDOSCOPIC HEMOSTASIS DEVICES
7.2.2 LIMITED AWARENESS IN LOW-INCOME COUNTRIES
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMOSTASIS DEVICES
7.3.2 EXPANSION IN EMERGING MARKETS (ASIA-PACIFIC, LATIN AMERICA)
7.3.3 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS
7.4 CHALLENGES
7.4.1 REIMBURSEMENT ISSUES FOR ENDOSCOPIC PROCEDURES
7.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES
8 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 MECHANICAL HEMOSTASIS DEVICES
8.2.1 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.2.1.1 HEMOSTATIC CLIPS
8.2.1.1.1 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE
8.2.1.1.1.1 THROUGH-THE-SCOPE (TTS) CLIPS
8.2.1.1.1.2 OVER-THE-SCOPE (OTS) CLIPS
8.2.1.1.2 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL
8.2.1.1.2.1 STAINLESS STEEL
8.2.1.1.2.2 TITANIUM
8.2.1.2 BANDING DEVICES
8.2.1.2.1 BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE
8.2.1.2.1.1 VARICEAL BANDING KITS
8.2.1.2.1.2 OESOPHAGEAL BANDING DEVICES
8.2.1.3 HEMOSTATIC FORCEPS
8.2.1.4 OTHERS
8.2.2 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.2.2.1 NORTH AMERICA
8.2.2.2 EUROPE
8.2.2.3 ASIA-PACIFIC
8.2.2.4 SOUTH AMERICA
8.2.2.5 MIDDLE EAST & AFRICA
8.3 THERMAL DEVICES
8.3.1 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.3.1.1 ARGON PLASMA COAGULATORS
8.3.1.2 HEATER PROBES
8.3.1.3 BIPOLAR COAGULATION DEVICES
8.3.1.3.1 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE
8.3.1.3.1.1 MONOPOLAR
8.3.1.3.1.2 BIPOLAR
8.3.1.3.2 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION
8.3.1.3.2.1 UPPER GI BLEEDING
8.3.1.3.2.2 LOWER GI BLEEDING
8.3.1.4 OTHERS
8.3.2 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.3.2.1 NORTH AMERICA
8.3.2.2 EUROPE
8.3.2.3 ASIA-PACIFIC
8.3.2.4 SOUTH AMERICA
8.3.2.5 MIDDLE EAST & AFRICA
8.4 TOPICAL AGENTS AND INJECTABLES
8.4.1 TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
8.4.1.1 EPINEPHRINE INJECTION
8.4.1.2 HEMOSTATIC SPRAY (POWDER)
8.4.1.3 HEMOSTATIC GELS
8.4.1.4 FIBRIN SEALANTS
8.4.1.5 SCLEROSING AGENTS
8.4.2 TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.4.2.1 NORTH AMERICA
8.4.2.2 EUROPE
8.4.2.3 ASIA-PACIFIC
8.4.2.4 SOUTH AMERICA
8.4.2.5 MIDDLE EAST & AFRICA
8.5 OTHERS
8.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
8.5.1.1 NORTH AMERICA
8.5.1.2 EUROPE
8.5.1.3 ASIA-PACIFIC
8.5.1.4 SOUTH AMERICA
8.5.1.5 MIDDLE EAST & AFRICA
9 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 UPPER GASTROINTESTINAL ENDOSCOPY
9.2.1 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
9.2.1.1 BLEEDING ULCER MANAGEMENT
9.2.1.2 VARICEAL BLEEDING
9.2.1.3 DIEULAFOY LESION
9.2.2 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.2.2.1 NORTH AMERICA
9.2.2.2 EUROPE
9.2.2.3 ASIA-PACIFIC
9.2.2.4 SOUTH AMERICA
9.2.2.5 MIDDLE EAST & AFRICA
9.3 LOWER GASTROINTESTINAL ENDOSCOPY
9.3.1 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
9.3.1.1 COLONIC BLEEDING
9.3.1.2 DIVERTICULAR BLEEDING
9.3.2 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.3.2.1 NORTH AMERICA
9.3.2.2 EUROPE
9.3.2.3 ASIA-PACIFIC
9.3.2.4 SOUTH AMERICA
9.3.2.5 MIDDLE EAST & AFRICA
9.4 BRONCHOSCOPIC HEMOSTASIS
9.4.1 BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.4.1.1 NORTH AMERICA
9.4.1.2 EUROPE
9.4.1.3 ASIA-PACIFIC
9.4.1.4 SOUTH AMERICA
9.4.1.5 MIDDLE EAST & AFRICA
9.5 OTHERS
9.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
9.5.1.1 NORTH AMERICA
9.5.1.2 EUROPE
9.5.1.3 ASIA-PACIFIC
9.5.1.4 SOUTH AMERICA
9.5.1.5 MIDDLE EAST & AFRICA
10 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 GASTROINTESTINAL BLEEDING
10.2.1 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
10.2.1.1 PEPTIC ULCER BLEEDING
10.2.1.2 ESOPHAGEAL VARICES
10.2.1.3 COLORECTAL CANCERS
10.2.2 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.2.2.1 MECHANICAL HEMOSTASIS DEVICES
10.2.2.2 THERMAL DEVICES
10.2.2.3 TOPICAL AGENTS AND INJECTABLES
10.2.2.4 OTHERS
10.2.3 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.2.3.1 NORTH AMERICA
10.2.3.2 EUROPE
10.2.3.3 ASIA-PACIFIC
10.2.3.4 SOUTH AMERICA
10.2.3.5 MIDDLE EAST & AFRICA
10.3 NON-GASTROINTESTINAL BLEEDING
10.3.1 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
10.3.1.1 NASAL BLEEDING (EPISTAXIS)
10.3.1.2 POST-SURGICAL BLEEDING
10.3.2 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.3.2.1 MECHANICAL HEMOSTASIS DEVICES
10.3.2.2 THERMAL DEVICES
10.3.2.3 TOPICAL AGENTS & INJECTABLES
10.3.2.4 OTHERS
10.3.3 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
10.3.3.1 NORTH AMERICA
10.3.3.2 EUROPE
10.3.3.3 ASIA-PACIFIC
10.3.3.4 SOUTH AMERICA
10.3.3.5 MIDDLE EAST & AFRICA
10.4 TRAUMA MANAGEMENT
10.4.1 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
10.4.1.1 MECHANICAL HEMOSTASIS DEVICES
10.4.1.2 THERMAL DEVICES
10.4.1.3 TOPICAL AGENTS & INJECTABLES
10.4.1.4 OTHERS
10.4.2 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.4.2.1 NORTH AMERICA
10.4.2.2 EUROPE
10.4.2.3 ASIA-PACIFIC
10.4.2.4 SOUTH AMERICA
10.4.2.5 MIDDLE EAST & AFRICA
10.5 OTHERS
10.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
10.5.1.1 NORTH AMERICA
10.5.1.2 EUROPE
10.5.1.3 ASIA-PACIFIC
10.5.1.4 SOUTH AMERICA
10.5.1.5 MIDDLE EAST & AFRICA
11 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.2.1 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE
11.2.1.1 PUBLIC
11.2.1.2 PRIVATE
11.2.2 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.2.2.1 NORTH AMERICA
11.2.2.2 EUROPE
11.2.2.3 ASIA-PACIFIC
11.2.2.4 SOUTH AMERICA
11.2.2.5 MIDDLE EAST & AFRICA
11.3 AMBULATORY SURGERY CENTERS
11.3.1 AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.3.1.1 NORTH AMERICA
11.3.1.2 EUROPE
11.3.1.3 ASIA-PACIFIC
11.3.1.4 SOUTH AMERICA
11.3.1.5 MIDDLE EAST & AFRICA
11.4 SPECIALTY CLINICS
11.4.1 SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.4.1.1 NORTH AMERICA
11.4.1.2 EUROPE
11.4.1.3 ASIA-PACIFIC
11.4.1.4 SOUTH AMERICA
11.4.1.5 MIDDLE EAST & AFRICA
11.5 OTHERS
11.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
11.5.1.1 NORTH AMERICA
11.5.1.2 EUROPE
11.5.1.3 ASIA-PACIFIC
11.5.1.4 SOUTH AMERICA
11.5.1.5 MIDDLE EAST & AFRICA
12 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 INDIRECT SALES
12.2.1 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE
12.2.1.1 OFFLINE
12.2.1.2 ONLINE
12.2.2 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
12.2.2.1 NORTH AMERICA
12.2.2.2 EUROPE
12.2.2.3 ASIA-PACIFIC
12.2.2.4 SOUTH AMERICA
12.2.2.5 MIDDLE EAST & AFRICA
12.3 DIRECT SALES
12.3.1 DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
12.3.1.1 NORTH AMERICA
12.3.1.2 EUROPE
12.3.1.3 ASIA-PACIFIC
12.3.1.4 SOUTH AMERICA
12.3.1.5 MIDDLE EAST & AFRICA
13 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 NETHERLANDS
13.1.7 BELGIUM
13.1.8 SWITZERLAND
13.1.9 SWEDEN
13.1.10 DENMARK
13.1.11 NORWAY
13.1.12 FINLAND
13.1.13 RUSSIA
13.1.14 TURKEY
13.1.15 REST OF EUROPE
14 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
15 SWOT ANALYSIS
16 COMPANY PROFILES MANUFACTURERS
16.1 OLYMPUS CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 BOSTON SCIENTIFIC CORPORATION
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CONMED CORPORATION
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 MEDTRONIC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 COOK
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ANKAFERD
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVEOPMENT
16.7 B. BRAUN SE
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVEOPMENT
16.8 CREO MEDICAL GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 DIVERSATEK, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVEOPMENT
16.1 DUOMED GROUP
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVEOPMENT
16.11 ENDOCLOT PLUS, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVEOPMENT
16.12 ERBE ELEKTROMEDIZIN GMBH
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FUJIFILM HOLDINGS CORPORATION
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 JOHNSON & JOHNSON (ETHICON)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVEOPMENT
16.15 KARL STORZ SE & CO. KG, TUTTLINGEN
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVEOPMENT
16.16 MEDITALIA S.R.L.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MICRO-TECH ENDOSCOPY
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 MTW ENDOSKOPIE MANUFAKTU
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVEOPMENT
16.19 OVESCO ENDOSCOPY AG
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVEOPMENT
16.2 PENTAX MEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 STERIS
16.21.1 COMPANY SNAPSHOT
16.21.2 REVENUE ANALYSIS
16.21.3 PRODUCT PORTFOLIO
16.21.4 RECENT DEVELOPMENT
17 COMPANY PROFILES DISTRIBUTOR
17.1 BOSTON IVY HEALTHCARE SOLUTIONS PRIVATE LIMITED
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 CARDINAL HEALTH
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVEOPMENT
17.3 HENRY SCHEIN, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVEOPMENT
17.4 MCKESSON MEDICAL-SURGICAL INC.
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVEOPMENT
17.5 MFI MEDICAL
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVEOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2 EUROPE MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 3 EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 4 EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 5 EUROPE BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 6 EUROPE MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 7 EUROPE THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 8 EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 9 EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 10 EUROPE THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 11 EUROPE TOPICAL AGENTS & INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 12 EUROPE TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 13 EUROPE OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 14 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 15 EUROPE UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 16 EUROPE UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 17 EUROPE LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 18 EUROPE LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 19 EUROPE BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 20 EUROPE OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 21 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 22 EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 24 EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 25 EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 27 EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 28 EUROPE TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 29 EUROPE TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 30 EUROPE OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 31 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 32 EUROPE HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 33 EUROPE HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 34 EUROPE AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 35 EUROPE SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 36 EUROPE OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 37 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 38 EUROPE INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 39 EUROPE INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 40 EUROPE DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND)
TABLE 41 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 42 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 EUROPE MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 44 EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 45 EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 46 EUROPE BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 47 EUROPE THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 48 EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 49 EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 50 EUROPE TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 51 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 52 EUROPE UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 53 EUROPE LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 54 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 55 EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 56 EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 57 EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 59 EUROPE TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 60 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 61 EUROPE HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 62 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 63 EUROPE INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 64 GERMANY ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 65 GERMANY MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 GERMANY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 67 GERMANY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 68 GERMANY BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 69 GERMANY THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 70 GERMANY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 71 GERMANY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 72 GERMANY TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 73 GERMANY ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 74 GERMANY UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 75 GERMANY LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 GERMANY ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 77 GERMANY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 78 GERMANY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 79 GERMANY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 GERMANY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 81 GERMANY TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 82 GERMANY ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 83 GERMANY HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 GERMANY ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 85 GERMANY INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 U.K. ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 87 U.K. MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 88 U.K. HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 U.K. HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 90 U.K. BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 91 U.K. THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 U.K. BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 U.K. BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 94 U.K. TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 U.K. ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 96 U.K. UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 97 U.K. LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 98 U.K. ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 99 U.K. GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 U.K. GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 U.K. NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 102 U.K. NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 103 U.K. TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 U.K. ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 105 U.K. HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 106 U.K. ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 107 U.K. INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 FRANCE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 109 FRANCE MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 110 FRANCE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 FRANCE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 112 FRANCE BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 113 FRANCE THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 FRANCE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 115 FRANCE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 116 FRANCE TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 FRANCE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 118 FRANCE UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 FRANCE LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 120 FRANCE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 121 FRANCE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 FRANCE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 123 FRANCE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 124 FRANCE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 125 FRANCE TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 126 FRANCE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 127 FRANCE HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 FRANCE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 129 FRANCE INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 130 ITALY ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 131 ITALY MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 132 ITALY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 133 ITALY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 134 ITALY BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 ITALY THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 ITALY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 137 ITALY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 138 ITALY TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 139 ITALY ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 140 ITALY UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 141 ITALY LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 ITALY ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 143 ITALY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 144 ITALY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 ITALY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 ITALY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 147 ITALY TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 148 ITALY ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 149 ITALY HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 150 ITALY ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 151 ITALY INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 152 SPAIN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 153 SPAIN MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 SPAIN HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 155 SPAIN HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 156 SPAIN BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 157 SPAIN THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 158 SPAIN BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 159 SPAIN BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 160 SPAIN TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 161 SPAIN ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 162 SPAIN UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 SPAIN LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 SPAIN ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 165 SPAIN GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 166 SPAIN GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 167 SPAIN NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 168 SPAIN NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 SPAIN TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 SPAIN ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 171 SPAIN HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 172 SPAIN ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 173 SPAIN INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 NETHERLANDS ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 175 NETHERLANDS MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 176 NETHERLANDS HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 NETHERLANDS HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 178 NETHERLANDS BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 179 NETHERLANDS THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 180 NETHERLANDS BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 NETHERLANDS BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 182 NETHERLANDS TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 183 NETHERLANDS ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 184 NETHERLANDS UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 185 NETHERLANDS LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 186 NETHERLANDS ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 187 NETHERLANDS GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 188 NETHERLANDS GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 189 NETHERLANDS NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 190 NETHERLANDS NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 NETHERLANDS TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 192 NETHERLANDS ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 193 NETHERLANDS HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 194 NETHERLANDS ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 195 NETHERLANDS INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 196 BELGIUM ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 BELGIUM MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 BELGIUM HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 199 BELGIUM HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 200 BELGIUM BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 BELGIUM THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 202 BELGIUM BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 203 BELGIUM BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 204 BELGIUM TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 BELGIUM ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 206 BELGIUM UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 207 BELGIUM LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 208 BELGIUM ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 209 BELGIUM GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 210 BELGIUM GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 211 BELGIUM NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 BELGIUM NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 213 BELGIUM TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 214 BELGIUM ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 215 BELGIUM HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 BELGIUM ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 217 BELGIUM INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 218 SWITZERLAND ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 219 SWITZERLAND MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 220 SWITZERLAND HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 221 SWITZERLAND HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 222 SWITZERLAND BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 223 SWITZERLAND THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 224 SWITZERLAND BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 225 SWITZERLAND BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 226 SWITZERLAND TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 227 SWITZERLAND ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 228 SWITZERLAND UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 229 SWITZERLAND LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 230 SWITZERLAND ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 231 SWITZERLAND GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 SWITZERLAND GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 SWITZERLAND NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 234 SWITZERLAND NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 235 SWITZERLAND TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 236 SWITZERLAND ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 237 SWITZERLAND HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 238 SWITZERLAND ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 239 SWITZERLAND INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 240 SWEDEN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 SWEDEN MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 242 SWEDEN HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 243 SWEDEN HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 244 SWEDEN BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 245 SWEDEN THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 246 SWEDEN BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 247 SWEDEN BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 248 SWEDEN TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 249 SWEDEN ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 250 SWEDEN UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 251 SWEDEN LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 252 SWEDEN ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 253 SWEDEN GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 254 SWEDEN GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 255 SWEDEN NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 256 SWEDEN NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 257 SWEDEN TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 SWEDEN ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 259 SWEDEN HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 260 SWEDEN ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 261 SWEDEN INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 262 DENMARK ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 263 DENMARK MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 264 DENMARK HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 265 DENMARK HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 266 DENMARK BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 DENMARK THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 DENMARK BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 269 DENMARK BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 270 DENMARK TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 271 DENMARK ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 272 DENMARK UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 273 DENMARK LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 274 DENMARK ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 275 DENMARK GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 DENMARK GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 277 DENMARK NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 278 DENMARK NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 279 DENMARK TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 280 DENMARK ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 281 DENMARK HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 282 DENMARK ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 283 DENMARK INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 284 NORWAY ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 285 NORWAY MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 NORWAY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 287 NORWAY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 288 NORWAY BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 289 NORWAY THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 290 NORWAY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 291 NORWAY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 292 NORWAY TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 293 NORWAY ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 294 NORWAY UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 295 NORWAY LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 296 NORWAY ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 297 NORWAY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 298 NORWAY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 299 NORWAY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 300 NORWAY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 301 NORWAY TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 302 NORWAY ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 303 NORWAY HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 304 NORWAY ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 305 NORWAY INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 306 FINLAND ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 307 FINLAND MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 308 FINLAND HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 FINLAND HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 310 FINLAND BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 311 FINLAND THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 312 FINLAND BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 313 FINLAND BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 314 FINLAND TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 315 FINLAND ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 316 FINLAND UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 FINLAND LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 318 FINLAND ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 319 FINLAND GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 320 FINLAND GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 321 FINLAND NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 322 FINLAND NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 323 FINLAND TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 324 FINLAND ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 325 FINLAND HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 326 FINLAND ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 327 FINLAND INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 328 RUSSIA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 329 RUSSIA MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 330 RUSSIA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 331 RUSSIA HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 332 RUSSIA BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 333 RUSSIA THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 334 RUSSIA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 335 RUSSIA BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 336 RUSSIA TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 RUSSIA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 338 RUSSIA UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 RUSSIA LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 340 RUSSIA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 341 RUSSIA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 342 RUSSIA GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 343 RUSSIA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 RUSSIA NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 345 RUSSIA TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 RUSSIA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 347 RUSSIA HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 348 RUSSIA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 349 RUSSIA INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 350 TURKEY ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 351 TURKEY MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 352 TURKEY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 353 TURKEY HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 354 TURKEY BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 355 TURKEY THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 356 TURKEY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 357 TURKEY BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 358 TURKEY TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 359 TURKEY ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 360 TURKEY UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 361 TURKEY LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 362 TURKEY ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 363 TURKEY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 364 TURKEY GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 365 TURKEY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 TURKEY NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 367 TURKEY TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 368 TURKEY ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 369 TURKEY HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 370 TURKEY ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 371 TURKEY INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 REST OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 373 REST OF EUROPE MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 374 REST OF EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 REST OF EUROPE HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL, 2018-2033 (USD THOUSAND)
TABLE 376 REST OF EUROPE BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 377 REST OF EUROPE THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 378 REST OF EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 REST OF EUROPE BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 380 REST OF EUROPE TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 REST OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE, 2018-2033 (USD THOUSAND)
TABLE 382 REST OF EUROPE UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 383 REST OF EUROPE LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 REST OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 385 REST OF EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 386 REST OF EUROPE GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 387 REST OF EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 388 REST OF EUROPE NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 389 REST OF EUROPE TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 390 REST OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 391 REST OF EUROPE HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 392 REST OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 393 REST OF EUROPE INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE, 2018-2033 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: SEGMENTATION
FIGURE 2 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: MULTIVARIATE MODELLING
FIGURE 8 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: MARKET END-USER COVERAGE GRID
FIGURE 11 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: SEGMENTATION
FIGURE 12 TWO SEGMENTS COMPRISE THE DOMINICAN REPUBLIC ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
FIGURE 13 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: EXECUTIVE SUMMARY
FIGURE 14 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: STRATEGIC DECISIONS
FIGURE 15 RISING PREVALANCE OF ENDOSCOPIC HEMOSTASIS CASES EXPECTED TO DRIVE THE GROWTH OF THE EUROPE ENDOSCOPIC HEMOSTASIS MARKET FROM 2026 TO 2033
FIGURE 16 THE TYPE 2 ENDOSCOPIC HEMOSTASIS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ENDOSCOPIC HEMOSTASIS MARKET IN 2026 & 2033
FIGURE 17 COMPANY EVALUATION QUADRANT
FIGURE 18 DROC ANALYSIS
FIGURE 19 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE, 2025
FIGURE 20 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , CAGR (2025-2032)
FIGURE 21 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , CAGR (2025-2032)
FIGURE 22 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY PRODUCT TYPE , LIFELINE CURVE (2025-2032)
FIGURE 23 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE, 2025
FIGURE 24 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY PROCEDURE , 2026-2033 (USD THOUSAND)
FIGURE 25 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY PROCEDURE , 2026-2033 (USD THOUSAND)
FIGURE 26 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION, 2025
FIGURE 27 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 28 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 29 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY APPLICATION, 2026-2033 (USD THOUSAND)
FIGURE 30 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER, 2025
FIGURE 31 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 32 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 33 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 34 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 35 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 36 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 37 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 38 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: SNAPSHOT (2025)
FIGURE 39 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: COMPANY SHARE 2025 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
